Premium
Targeting angiogenesis in chronic liver diseases with portal hypertension: anti–placenta growth factor inhibitor or multikinase inhibitor sorafenib?
Author(s) -
Coriat Romain,
Mir Olivier,
Goldwasser François,
Pol Stanislas,
Chaussade Stanislas
Publication year - 2011
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.24688
Subject(s) - sorafenib , medicine , placental growth factor , hepatocellular carcinoma , portal venous pressure , portal hypertension , angiogenesis , vascular endothelial growth factor , kinase insert domain receptor , gastroenterology , pharmacology , oncology , endocrinology , cirrhosis , cancer research , vascular endothelial growth factor a , vegf receptors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom